Related Experiment Video
Updated: Mar 7, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Obesity challenges the hepatoprotective function of the integrated stress response to asparaginase exposure in mice
Inna A Nikonorova1, Rana J T Al-Baghdadi2, Emily T Mirek1
1From the Department of Nutritional Sciences, and.
Abstract:
Obesity increases risk for liver toxicity by the anti-leukemic agent asparaginase, but the mechanism is unknown. Asparaginase activates the integrated stress response (ISR) via sensing amino acid depletion by the eukaryotic initiation factor 2 (eIF2) kinase GCN2. The goal of this work was to discern the impact of obesity, alone versus alongside genetic disruption of the ISR, on mechanisms of liver protection during chronic asparaginase exposure in mice. Following diet-induced obesity, biochemical analysis of livers revealed that asparaginase provoked hepatic steatosis that coincided with activation of another eIF2 kinase PKR-like endoplasmic reticulum kinase (PERK), a major ISR transducer to ER stress. Genetic loss of Gcn2 intensified hepatic PERK activation to asparaginase, yet surprisingly, mRNA levels of key ISR gene targets such as Atf5 and Trib3 failed to increase. Instead, mechanistic target of rapamycin complex 1 (mTORC1) signal transduction was unleashed, and this coincided with liver dysfunction reflected by a failure to maintain hydrogen sulfide production or apolipoprotein B100 (ApoB100) expression. In contrast, obese mice lacking hepatic activating transcription factor 4 (Atf4) showed an exaggerated ISR and greater loss of endogenous hydrogen sulfide but normal inhibition of mTORC1 and maintenance of ApoB100 during asparaginase exposure. In both genetic mouse models, expression and phosphorylation of Sestrin2, an ATF4 gene target, was increased by asparaginase, suggesting mTORC1 inhibition during asparaginase exposure is not driven via eIF2-ATF4-Sestrin2. In conclusion, obesity promotes a maladaptive ISR during asparaginase exposure. GCN2 functions to repress mTORC1 activity and maintain ApoB100 protein levels independently of Atf4 expression, whereas hydrogen sulfide production is promoted via GCN2-ATF4 pathway.
Insights
Obesity worsens liver toxicity from asparaginase by disrupting the integrated stress response (ISR). GCN2 normally represses mTORC1, but its loss in obesity unleashes mTORC1, causing liver dysfunction and impacting protein and hydrogen sulfide levels.
Area of Science:
- Biochemistry
- Cellular Biology
- Toxicology
Background:
- Obesity exacerbates liver toxicity induced by the anti-leukemic drug asparaginase through unknown mechanisms.
- Asparaginase triggers the integrated stress response (ISR) by activating the GCN2 kinase due to amino acid depletion.
Purpose of the Study:
- To investigate how obesity, with or without ISR genetic disruption, affects liver protection during chronic asparaginase treatment in mice.
- To elucidate the specific roles of GCN2 and PERK in mediating asparaginase-induced liver toxicity in obese mice.
Main Methods:
- Diet-induced obesity model in mice.
- Biochemical analysis of liver tissues.
- Genetic manipulation of ISR components (Gcn2, Atf4).
- Measurement of ISR gene targets, mTORC1 signaling, hydrogen sulfide production, and apolipoprotein B100 expression.
Main Results:
- Obesity promoted hepatic steatosis and PERK activation upon asparaginase exposure.
- Loss of GCN2 intensified PERK activation but paradoxically reduced ISR gene expression, leading to mTORC1 activation and liver dysfunction.
- Mice lacking Atf4 exhibited an exaggerated ISR and reduced hydrogen sulfide but maintained normal mTORC1 signaling and ApoB100 expression.
- Asparaginase increased Sestrin2, but this did not appear to mediate mTORC1 inhibition via the eIF2-ATF4-Sestrin2 pathway.
Conclusions:
- Obesity promotes a detrimental ISR during asparaginase therapy.
- GCN2 plays a crucial role in suppressing mTORC1 activity and maintaining ApoB100 levels, independent of Atf4.
- The GCN2-ATF4 pathway is essential for promoting hydrogen sulfide production during asparaginase treatment.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

